Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:49 UTC
Update Date2022-03-07 02:51:35 UTC
HMDB IDHMDB0014356
Secondary Accession Numbers
  • HMDB14356
Metabolite Identification
Common NameMidodrine
DescriptionMidodrine is only found in individuals that have used or taken this drug. It is an ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension. [PubChem]Midodrine forms an active metabolite, desglymidodrine, that is an alpha1-agonist, and exerts its actions via activation of the alpha-adrenergic receptors of the arteriolar and venous vasculature, producing an increase in vascular tone and elevation of blood pressure. Desglymidodrine does not stimulate cardiac beta-adrenergic receptors.
Structure
Data?1582753168
Synonyms
ValueSource
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamideChEBI
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanolChEBI
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamideChEBI
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamidChEBI
MidodrinaChEBI
MidodrinumChEBI
(+-)-2-Amino-N-(b-hydroxy-2,5-dimethoxyphenethyl)acetamideGenerator
(+-)-2-Amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamideGenerator
2-Amino-N-(2,5-dimethoxy-b-hydroxyphenethyl)acetamideGenerator
2-Amino-N-(2,5-dimethoxy-β-hydroxyphenethyl)acetamideGenerator
DL-N1-(b-Hydroxy-2,5-dimethoxyphenethyl)glycinamidGenerator
DL-N1-(Β-hydroxy-2,5-dimethoxyphenethyl)glycinamidGenerator
MidodrinHMDB
Midodrine HCLHMDB
Midodrine hydrochlorideHMDB
AmatineHMDB
Cahill may roberts brand OF midodrine monohydrochlorideHMDB
Nycomed brand OF midodrine monohydrochlorideHMDB
Christiaens brand OF midodrine monohydrochlorideHMDB
Monohydrochloride, midodrineHMDB
ProAmatineHMDB
Shire brand OF midodrine monohydrochlorideHMDB
Midodrine monohydrochlorideHMDB
GutronHMDB
MidonHMDB
Chemical FormulaC12H18N2O4
Average Molecular Weight254.2823
Monoisotopic Molecular Weight254.126657074
IUPAC Name2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide
Traditional Namemidodrine
CAS Registry Number133163-28-7
SMILES
COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1
InChI Identifier
InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)
InChI KeyPTKSEFOSCHHMPD-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassMethoxybenzenes
Direct ParentDimethoxybenzenes
Alternative Parents
Substituents
  • P-dimethoxybenzene
  • Dimethoxybenzene
  • Phenoxy compound
  • Anisole
  • Phenol ether
  • Alkyl aryl ether
  • Secondary alcohol
  • Carboximidic acid
  • Carboximidic acid derivative
  • Ether
  • Propargyl-type 1,3-dipolar organic compound
  • Organic 1,3-dipolar compound
  • Organopnictogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Amine
  • Organic nitrogen compound
  • Alcohol
  • Primary amine
  • Hydrocarbon derivative
  • Aromatic alcohol
  • Organic oxygen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point200 - 203 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility4.45 g/LNot Available
LogP-0.5Not Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility4.45 g/LALOGPS
logP-0.49ALOGPS
logP-0.95ChemAxon
logS-1.8ALOGPS
pKa (Strongest Acidic)13.77ChemAxon
pKa (Strongest Basic)8.14ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area93.81 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity66.22 m³·mol⁻¹ChemAxon
Polarizability26.65 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+159.2431661259
DarkChem[M-H]-159.67131661259
DeepCCS[M+H]+160.09830932474
DeepCCS[M-H]-157.7430932474
DeepCCS[M-2H]-190.62630932474
DeepCCS[M+Na]+166.19130932474
AllCCS[M+H]+159.332859911
AllCCS[M+H-H2O]+155.732859911
AllCCS[M+NH4]+162.632859911
AllCCS[M+Na]+163.532859911
AllCCS[M-H]-159.832859911
AllCCS[M+Na-2H]-160.232859911
AllCCS[M+HCOO]-160.932859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.2.12 minutes32390414
Predicted by Siyang on May 30, 20229.7738 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20225.6 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid106.1 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid921.5 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid228.8 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid121.0 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid172.9 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid77.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid259.2 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid324.2 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)637.3 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid684.1 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid237.2 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid877.4 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid208.6 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid226.8 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate455.8 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA363.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water59.6 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MidodrineCOC1=CC(C(O)CNC(=O)CN)=C(OC)C=C13313.4Standard polar33892256
MidodrineCOC1=CC(C(O)CNC(=O)CN)=C(OC)C=C12217.6Standard non polar33892256
MidodrineCOC1=CC(C(O)CNC(=O)CN)=C(OC)C=C12373.7Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Midodrine,1TMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN)O[Si](C)(C)C)=C12320.3Semi standard non polar33892256
Midodrine,1TMS,isomer #2COC1=CC=C(OC)C(C(O)CNC(=O)CN[Si](C)(C)C)=C12402.0Semi standard non polar33892256
Midodrine,1TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN)[Si](C)(C)C)=C12282.2Semi standard non polar33892256
Midodrine,2TMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN[Si](C)(C)C)O[Si](C)(C)C)=C12358.2Semi standard non polar33892256
Midodrine,2TMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN[Si](C)(C)C)O[Si](C)(C)C)=C12293.4Standard non polar33892256
Midodrine,2TMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN[Si](C)(C)C)O[Si](C)(C)C)=C13141.2Standard polar33892256
Midodrine,2TMS,isomer #2COC1=CC=C(OC)C(C(CN(C(=O)CN)[Si](C)(C)C)O[Si](C)(C)C)=C12296.9Semi standard non polar33892256
Midodrine,2TMS,isomer #2COC1=CC=C(OC)C(C(CN(C(=O)CN)[Si](C)(C)C)O[Si](C)(C)C)=C12291.7Standard non polar33892256
Midodrine,2TMS,isomer #2COC1=CC=C(OC)C(C(CN(C(=O)CN)[Si](C)(C)C)O[Si](C)(C)C)=C13245.5Standard polar33892256
Midodrine,2TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)=C12359.6Semi standard non polar33892256
Midodrine,2TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)=C12508.4Standard non polar33892256
Midodrine,2TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)=C13194.9Standard polar33892256
Midodrine,2TMS,isomer #4COC1=CC=C(OC)C(C(O)CNC(=O)CN([Si](C)(C)C)[Si](C)(C)C)=C12502.2Semi standard non polar33892256
Midodrine,2TMS,isomer #4COC1=CC=C(OC)C(C(O)CNC(=O)CN([Si](C)(C)C)[Si](C)(C)C)=C12548.9Standard non polar33892256
Midodrine,2TMS,isomer #4COC1=CC=C(OC)C(C(O)CNC(=O)CN([Si](C)(C)C)[Si](C)(C)C)=C13265.9Standard polar33892256
Midodrine,3TMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12320.3Semi standard non polar33892256
Midodrine,3TMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12426.6Standard non polar33892256
Midodrine,3TMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12906.9Standard polar33892256
Midodrine,3TMS,isomer #2COC1=CC=C(OC)C(C(CNC(=O)CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12440.7Semi standard non polar33892256
Midodrine,3TMS,isomer #2COC1=CC=C(OC)C(C(CNC(=O)CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12475.0Standard non polar33892256
Midodrine,3TMS,isomer #2COC1=CC=C(OC)C(C(CNC(=O)CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12944.6Standard polar33892256
Midodrine,3TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C12458.4Semi standard non polar33892256
Midodrine,3TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C12664.0Standard non polar33892256
Midodrine,3TMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C13019.2Standard polar33892256
Midodrine,4TMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12484.3Semi standard non polar33892256
Midodrine,4TMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12578.8Standard non polar33892256
Midodrine,4TMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=C12774.8Standard polar33892256
Midodrine,1TBDMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN)O[Si](C)(C)C(C)(C)C)=C12597.1Semi standard non polar33892256
Midodrine,1TBDMS,isomer #2COC1=CC=C(OC)C(C(O)CNC(=O)CN[Si](C)(C)C(C)(C)C)=C12656.6Semi standard non polar33892256
Midodrine,1TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN)[Si](C)(C)C(C)(C)C)=C12554.5Semi standard non polar33892256
Midodrine,2TBDMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C12831.9Semi standard non polar33892256
Midodrine,2TBDMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C12747.1Standard non polar33892256
Midodrine,2TBDMS,isomer #1COC1=CC=C(OC)C(C(CNC(=O)CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13235.1Standard polar33892256
Midodrine,2TBDMS,isomer #2COC1=CC=C(OC)C(C(CN(C(=O)CN)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C12804.5Semi standard non polar33892256
Midodrine,2TBDMS,isomer #2COC1=CC=C(OC)C(C(CN(C(=O)CN)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C12701.0Standard non polar33892256
Midodrine,2TBDMS,isomer #2COC1=CC=C(OC)C(C(CN(C(=O)CN)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13303.9Standard polar33892256
Midodrine,2TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C12865.7Semi standard non polar33892256
Midodrine,2TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C12878.1Standard non polar33892256
Midodrine,2TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C13269.9Standard polar33892256
Midodrine,2TBDMS,isomer #4COC1=CC=C(OC)C(C(O)CNC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C12965.7Semi standard non polar33892256
Midodrine,2TBDMS,isomer #4COC1=CC=C(OC)C(C(O)CNC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C12869.5Standard non polar33892256
Midodrine,2TBDMS,isomer #4COC1=CC=C(OC)C(C(O)CNC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C13297.7Standard polar33892256
Midodrine,3TBDMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13046.7Semi standard non polar33892256
Midodrine,3TBDMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13014.8Standard non polar33892256
Midodrine,3TBDMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13156.8Standard polar33892256
Midodrine,3TBDMS,isomer #2COC1=CC=C(OC)C(C(CNC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13153.5Semi standard non polar33892256
Midodrine,3TBDMS,isomer #2COC1=CC=C(OC)C(C(CNC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13013.1Standard non polar33892256
Midodrine,3TBDMS,isomer #2COC1=CC=C(OC)C(C(CNC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13158.0Standard polar33892256
Midodrine,3TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C13162.1Semi standard non polar33892256
Midodrine,3TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C13123.8Standard non polar33892256
Midodrine,3TBDMS,isomer #3COC1=CC=C(OC)C(C(O)CN(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C13213.4Standard polar33892256
Midodrine,4TBDMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13379.0Semi standard non polar33892256
Midodrine,4TBDMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13259.1Standard non polar33892256
Midodrine,4TBDMS,isomer #1COC1=CC=C(OC)C(C(CN(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C13114.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Midodrine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0019-9420000000-7d9c097f5836b8a5fae72017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Midodrine GC-MS (1 TMS) - 70eV, Positivesplash10-0udi-2901000000-dca22bfb649bee6445c32017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Midodrine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 10V, Positive-QTOFsplash10-0a59-5590000000-c1d7a0986ff760045ce12016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 20V, Positive-QTOFsplash10-000t-3900000000-e616153c52e6dab85f032016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 40V, Positive-QTOFsplash10-05o0-6900000000-90bdd17739520c3682422016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 10V, Negative-QTOFsplash10-0udi-2290000000-2b1a688c778f1a3b4f732016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 20V, Negative-QTOFsplash10-0fki-9780000000-3ec6e31d870a13fc12772016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 40V, Negative-QTOFsplash10-0596-9510000000-f2530e4ed2f894325b442016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 10V, Positive-QTOFsplash10-0a4i-0290000000-be85220bae16e2ca879f2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 20V, Positive-QTOFsplash10-001i-1910000000-846cb5ab8c2f374a839a2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 40V, Positive-QTOFsplash10-0540-9600000000-457f0b777313d983dbcd2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 10V, Negative-QTOFsplash10-0udi-3290000000-bba27a0b4e7c20b0735e2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 20V, Negative-QTOFsplash10-00di-9600000000-75c1caa8420dbc10acec2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Midodrine 40V, Negative-QTOFsplash10-0pi3-5920000000-8736da98df9e10c5809c2021-09-24Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00211 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00211 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00211
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4050
KEGG Compound IDC07890
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkMidodrine
METLIN IDNot Available
PubChem Compound4195
PDB IDNot Available
ChEBI ID6933
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Hebenstreit G: [Treatment of hypotension caused by psychopharmacological drugs (author's transl)]. Wien Med Wochenschr. 1981 Feb 28;131(4):109-12. [PubMed:6165144 ]
  2. Tsuda M, Terada T, Irie M, Katsura T, Niida A, Tomita K, Fujii N, Inui K: Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60. Epub 2006 Apr 5. [PubMed:16597710 ]

Enzymes

General function:
Involved in monooxygenase activity
Specific function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular weight:
55768.94
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins
Gene Name:
ADRA1A
Uniprot ID:
P35348
Molecular weight:
51486.0
References
  1. Buckner SA, Milicic I, Daza AV, Meyer MD, Altenbach RJ, Williams M, Sullivan JP, Brioni JD: ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes. Eur J Pharmacol. 2002 Aug 2;449(1-2):159-65. [PubMed:12163120 ]
  2. Taniguchi N, Hamada K, Ogasawara T, Ukai Y, Yoshikuni Y, Kimura K: NS-49, an alpha 1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs. Eur J Pharmacol. 1996 Dec 27;318(1):117-22. [PubMed:9007522 ]
  3. Altenbach RJ, Khilevich A, Kolasa T, Rohde JJ, Bhatia PA, Patel MV, Searle XB, Yang F, Bunnelle WH, Tietje K, Bayburt EK, Carroll WA, Meyer MD, Henry R, Buckner SA, Kuk J, Daza AV, Milicic IV, Cain JC, Kang CH, Ireland LM, Carr TL, Miller TR, Hancock AA, Nakane M, Esbenshade TA, Brune ME, O'Neill AB, Gauvin DM, Katwala SP, Holladay MW, Brioni JD, Sullivan JP: Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. J Med Chem. 2004 Jun 3;47(12):3220-35. [PubMed:15163201 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system
Gene Name:
ADRA1B
Uniprot ID:
P35368
Molecular weight:
56835.4
References
  1. Altenbach RJ, Khilevich A, Kolasa T, Rohde JJ, Bhatia PA, Patel MV, Searle XB, Yang F, Bunnelle WH, Tietje K, Bayburt EK, Carroll WA, Meyer MD, Henry R, Buckner SA, Kuk J, Daza AV, Milicic IV, Cain JC, Kang CH, Ireland LM, Carr TL, Miller TR, Hancock AA, Nakane M, Esbenshade TA, Brune ME, O'Neill AB, Gauvin DM, Katwala SP, Holladay MW, Brioni JD, Sullivan JP: Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. J Med Chem. 2004 Jun 3;47(12):3220-35. [PubMed:15163201 ]